Short answer
Fulgent Genetics, Inc. (FLGT) filed an 8-K current report with the SEC on February 27, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q4 and full-year 2025 earnings released Feb 27, 2026: details in Exhibit 99.1.
Fulgent Genetics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 earnings released Feb 27, 2026: details in Exhibit 99.1
- Covers fiscal year ended Dec 31, 2025: full annual results included alongside quarterly figures
Item 7.01 · Regulation FD Disclosure
- Updated investor presentation published Feb 27, 2026, available on IR website and as Exhibit 99.2
- Reg FD disclosure ensures material business updates reach all investors simultaneously: limits information asymmetry
- Presentation "furnished" not "filed": not subject to SEC liability under Exchange Act Section 18; lower legal weight
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Fulgent Genetics, Inc. 8-K filings
Get the next FLGT 8-K as it lands
Follow FLGT for push alerts, or ask the research agent what this filing means.